Diagnostic challenge of delayed immune-related hepatitis during zongertinib treatment after nivolumab plus ipilimumab in a 52-year-old man with HER2-mutant non-small cell lung cancer: a case report.
- DOI
- 10.21037/tlcr-2026-0856
- Published
- 2026 Oct 30
- Container
- Translational lung cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2026-0856,
title = {Diagnostic challenge of delayed immune-related hepatitis during zongertinib treatment after nivolumab plus ipilimumab in a 52-year-old man with HER2-mutant non-small cell lung cancer: a case report.},
author = {Oba T and Shiohira S and Machida Y and Nakatani D and Akasaka K and Amano M and Matsushima H},
year = {2026},
journal = {Translational lung cancer research},
doi = {10.21037/tlcr-2026-0856},
url = {https://doi.org/10.21037/tlcr-2026-0856}
}RIS
TY - JOUR TI - Diagnostic challenge of delayed immune-related hepatitis during zongertinib treatment after nivolumab plus ipilimumab in a 52-year-old man with HER2-mutant non-small cell lung cancer: a case report. AU - Oba T AU - Shiohira S AU - Machida Y AU - Nakatani D AU - Akasaka K AU - Amano M AU - Matsushima H PY - 2026 JO - Translational lung cancer research DO - 10.21037/tlcr-2026-0856 UR - https://doi.org/10.21037/tlcr-2026-0856 ER -
APA
T, O., S, S., Y, M., D, N., K, A., M, A., & H, M. (2026). Diagnostic challenge of delayed immune-related hepatitis during zongertinib treatment after nivolumab plus ipilimumab in a 52-year-old man with HER2-mutant non-small cell lung cancer: a case report.. Translational lung cancer research. https://doi.org/10.21037/tlcr-2026-0856
Source records
- pubmed · retrieved 2026-11-10T12:21:07.628Z
- europe-pmc · retrieved 2026-11-10T12:21:07.638Z